Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Helix logo — Helix is the leading population genomics and precision healt...

Helix

Helix is the leading population genomics and precision health organization.

Founded 2015 United States San Mateo, United States 596 employees Series C Total: $411.00M Big Data, Biotechnology +6

General Information

Company Name Helix
Founded Year 2015
Location United States San Mateo, United States
Employees 596
Industries Big Data, Biotechnology, Blockchain +5
Funding Stage Series C
Business Model B2B, B2B2C, Platform
Revenue Model Service Fee, Data Monetization, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Helix. To contact Helix, visit helix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Helix

Helix, founded in 2015, is a pioneer in the integration of genomic data within the healthcare sector, positioning itself as a leader in population genomics and precision health. The company collaborates with health systems, life sciences companies, and payers to foster the adoption of genomic data in patient care and therapeutic development.

Based in the United States, Helix operates at the intersection of several cutting-edge industries, including Big Data, Biotechnology, and Health Care. This positions the company to capitalize on the increasing demand for advanced health solutions and data integration capabilities across numerous market segments.

In June 2021, Helix secured a $50.00M investment in its Series C funding round, with participation from prominent investors such as Kleiner Perkins, DFJ Growth, Warburg Pincus, Mayo Clinic, and Temasek. This substantial backing underscores investor confidence in Helix's growth potential and its innovative approach to genomics integration in healthcare.

Taxonomy: Population Genomics, Precision Health, Precision Medicine, Next Generation Sequencing, Exome Sequencing, Bioinformatics, Genomic Data Integration, Clinical Care, Therapeutic Development, Translational Research, Health System Strategy, CLIA/CAP Certified Lab, Exome+ Assay, Disease Screening, Genomic Research

Services & Products

Seamless Genetic Testing
Population Genomics Solutions
Genomic Data Integration
Precision Health Network
Comprehensive Genomic Insights

Target Customers

Healthcare Providers Health Systems Life Sciences Organizations Patients Research Participants

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $50.00M 5
Kleiner Perkins DFJ Growth Warburg Pincus
Kleiner Perkins, DFJ Growth +3
01 Jun 2021
Grant $33.00M 1
National Institute of Health
National Institute of Health
01 Jul 2020
Series B $200.00M 7
Kleiner Perkins DFJ Growth Warburg Pincus
Kleiner Perkins, DFJ Growth +5
01 Mar 2018
Early VC $20.00M 2
Kleiner Perkins Casdin Capital
Kleiner Perkins, Casdin Capital
01 Oct 2017
Series A $100.00M 5
LaunchCapital Warburg Pincus Sutter Hill Ventures
LaunchCapital, Warburg Pincus +3
01 Aug 2015
Series A $8.00M 4
Obvious Ventures Andreessen Horowitz/ a16z Borealis Ventures
Obvious Ventures, Andreessen Horowitz/ a16z +2
01 May 2014
Seed Undisclosed -
01 Feb 2009

Helix Alternatives & Competitors

View All Alternatives
Helix vs
Artisan Biomed
Artisan Biomed South Africa

Unraveling the African Genome to transform health care

1 employees
Biotechnology, Health and Wellness
Helix vs
Genomics
Genomics United Kingdom

Transforming health, healthcare and drug discovery and development through the power of genomics

186 employees
Biopharma, Biotechnology
Helix vs
Fabric Genomics
Fabric Genomics United States

AI‑Driven Clinical Insights for Genomic Data

Venture round
27 employees
AI, Biotechnology
Also compare with: Helix vs Ashion Analytics Ashion Analytics Helix vs Mendelics Mendelics View all alternatives

FAQ About Helix

Helix is the leading population genomics and precision health organization.
Helix was founded in 2015.
Helix is headquartered in San Mateo, United States.
Helix operates in Big Data, Biotechnology, Blockchain, Crypto, Fintech, Health Care, Health and Wellness and Clean Energy. Its work centres on Population Genomics, Precision Health, Precision Medicine and Next Generation Sequencing. Its customers include Healthcare Providers, Health Systems and Life Sciences Organizations.
Helix has a B2B, B2B2C and Platform business model. Its revenue comes from Service Fee, Data Monetization and Subscription.
Helix has approximately 596 employees.
Helix has completed 7 funding rounds, raising a total of $411.00M. The latest funding stage is Series C.
Helix offers: Seamless Genetic Testing, Population Genomics Solutions, Genomic Data Integration, Precision Health Network, Comprehensive Genomic Insights.
Top alternatives and competitors to Helix include Artisan Biomed, Genomics, Fabric Genomics, Ashion Analytics, Strata Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Helix and Artisan Biomed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Helix, https://bouncewatch.com/company/helix-1, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes